We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$19.1B
AUM Growth
-$71.6M
Cap. Flow
+$375M
Cap. Flow %
1.97%
Top 10 Hldgs %
20.96%
Holding
1,713
New
9
Increased
554
Reduced
98
Closed
38

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$83.2M
2
DQ
Daqo New Energy
DQ
+$42.7M
3
DAR icon
Darling Ingredients
DAR
+$33M
4
TER icon
Teradyne
TER
+$25.8M
5
IQV icon
IQVIA
IQV
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Healthcare 17.68%
3 Consumer Discretionary 14.03%
4 Financials 13.08%
5 Industrials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPA icon
1601
Copa Holdings
CPA
$6.21B
$285K ﹤0.01%
3,500
AMWL icon
1602
American Well
AMWL
$225M
$284K ﹤0.01%
1,560
REAL icon
1603
The RealReal
REAL
$1.35B
$281K ﹤0.01%
21,300
SAVE
1604
DELISTED
Spirit Airlines, Inc.
SAVE
$280K ﹤0.01%
10,800
KURA icon
1605
Kura Oncology
KURA
$970M
$277K ﹤0.01%
14,800
LRN icon
1606
Stride
LRN
$3.36B
$277K ﹤0.01%
7,700
ANDE icon
1607
Andersons Inc
ANDE
$2.24B
$275K ﹤0.01%
8,923
ZGNX
1608
DELISTED
Zogenix, Inc.
ZGNX
$275K ﹤0.01%
18,100
CCF
1609
DELISTED
Chase Corporation
CCF
$274K ﹤0.01%
2,686
JMIA
1610
Jumia Technologies
JMIA
$782M
$273K ﹤0.01%
14,700
JRVR icon
1611
James River Group Holdings
JRVR
$206M
$269K ﹤0.01%
7,137
TCMD icon
1612
Tactile Systems Technology
TCMD
$547M
$267K ﹤0.01%
6,000
INO icon
1613
Inovio Pharmaceuticals
INO
$90.3M
$265K ﹤0.01%
3,083
MGNX icon
1614
MacroGenics
MGNX
$271M
$264K ﹤0.01%
12,600
NP
1615
DELISTED
Neenah, Inc. Common Stock
NP
$264K ﹤0.01%
5,665
DHC
1616
Diversified Healthcare Trust
DHC
$2.04B
$263K ﹤0.01%
77,678
STTK icon
1617
Shattuck Labs
STTK
$756M
$261K ﹤0.01%
12,800
FIZZ icon
1618
National Beverage
FIZZ
$2.94B
$260K ﹤0.01%
4,958
ALX
1619
Alexander's
ALX
$1.41B
$259K ﹤0.01%
993
PRPL icon
1620
Purple Innovation
PRPL
$28.8M
$259K ﹤0.01%
492
TEVA icon
1621
Teva Pharmaceuticals
TEVA
$42.9B
$258K ﹤0.01%
26,500
MCRB icon
1622
Seres Therapeutics
MCRB
$46.3M
$254K ﹤0.01%
1,825
+1,025
+128% +$201K
YEXT icon
1623
Yext
YEXT
$588M
$251K ﹤0.01%
20,900
IMGN
1624
DELISTED
Immunogen Inc
IMGN
$246K ﹤0.01%
43,300
AIV
1625
Aimco
AIV
$381M
$245K ﹤0.01%
35,748

Similar funds

Handelsbanken Fonder's Q3 2021 Portfolio in Review

As of Q3 2021, Handelsbanken Fonder held 1,713 positions worth $19.1B, down 0.37% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. Handelsbanken Fonder opened 9 new positions and exited 38, leaving the 1,713-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q3 2021 buy was Volta Inc.: 1,671,677 shares worth $14.5M.
  • Handelsbanken Fonder added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $83.2M increase.
  • Handelsbanken Fonder's biggest Q3 2021 reduction was Amgen, cutting an estimated $49.3M.
  • Handelsbanken Fonder fully exited Johnson Controls International in Q3 2021, selling an estimated $19.2M.
  • Handelsbanken Fonder's ten largest holdings make up 21% of its $19.1B portfolio in Q3 2021.
  • Handelsbanken Fonder opened 9 new positions and closed 38 in Q3 2021.
  • Handelsbanken Fonder's portfolio value fell 0.37% quarter-over-quarter to $19.1B.

Based on Handelsbanken Fonder's 13F filing for Q3 2021, filed 10 Nov 2021.